Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus
A technology for markers and diabetes, applied in the diagnosis of susceptibility to type 2 diabetes, diagnosis of protection against type 2 diabetes, diagnosis of type 2 diabetes susceptibility reduction, and can solve problems such as unsatisfied
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0181]Described here is the identification of transcription factor 7-like 2 (TCF7L2-formerly TCF4) as a gene contributing to type 2 diabetes risk by single point association analysis using dense microsatellite markers within the 10q locus.
[0182] method
[0183] iceland group
[0184] The Data Protection Authority of Iceland and the National Bioethics Committee of Iceland approved the study. All study participants signed informed consent. All personally identifiable data related to blood samples, medical information and family pedigrees are first encrypted by the Data Protection Authority using a third-party encryption system(18) (Data Protection Authority).
[0185] For the study, 2,400 patients with type 2 diabetes were identified who had either been diagnosed during a long-term epidemiological study by the Icelandic Heart Association over the past 30 years or had been diagnosed in Reykjavik over the past 12 years. (Reykjavik) was diagnosed in two major hospitals. Tw...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
